ORMDL3
Summary:
Loading, please wait...
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
OMIM IDMIM:610075 Ensembl IDEnsembl:ENSG00000172057 HGNC IDHGNC:HGNC:16038 PHARMGKB IDPA32821 Map Location17q21.1 |
GO terms in ORMDL3
Loading, please wait...
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IBA | GO:0006672 | ceramide metabolic process |
BP | IMP | GO:0006672 | ceramide metabolic process |
BP | TAS | GO:0043312 | neutrophil degranulation |
BP | IBA | GO:0090156 | cellular sphingolipid homeostasis |
BP | IBA | GO:1900060 | negative regulation of ceramide biosynthetic process |
BP | IMP | GO:1900060 | negative regulation of ceramide biosynthetic process |
Gene expression in normal tissue: ORMDL3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ORMDL3
Loading, please wait...
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1430728 | Metabolism |
reactome | R-HSA-1660661 | Sphingolipid de novo biosynthesis |
reactome | R-HSA-168249 | Innate Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-428157 | Sphingolipid metabolism |
reactome | R-HSA-556833 | Metabolism of lipids |
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in ORMDL3
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |